Internal Medicine, Rheumatology · Port Charlotte, FL
NPI
1720004484
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
22226 Westchester Blvd
Port Charlotte, FL, 33952
Phone (941) 625-3402
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.8M
253,800 services
Medicare patients, 2024
567
Average age 74
Drug cost, 2024
$2.3M
4,544 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leslie Tar was code J3262 (injection, tocilizumab, 1 mg), 101,560 times for 33 patients. In total Leslie Tar billed 253,800 services in 49 codes, and Medicare paid $3.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 101,560 | 33 | $4.71 | $478K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 36,750 | 60 | $33.86 | $1.2M |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 22,850 | 130 | $0.23 | $5,199 |
| J2357 Injection, omalizumab, 5 mg | Office | 10,860 | 25 | $29.89 | $325K |
| J0897 Injection, denosumab, 1 mg | Office | 9,960 | 101 | $20.59 | $205K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 8,150 | 11 | $9.10 | $74K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,040 | 30 | $24.95 | $201K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,541 | 61 | $0.10 | $359 |
| 96415 Chemotherapy Administration | Office | 2,524 | 136 | $22.57 | $57K |
| 99214 Office E&M - Established | Office | 2,500 | 536 | $99.05 | $248K |
| 96375 Injection Administration | Office | 2,103 | 135 | $12.44 | $26K |
| 36415 Venipuncture Blood Collection | Office | 1,984 | 517 | $8.65 | $17K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 1,223 | 137 | $0.65 | $791 |
| 96413 Chemotherapy Administration | Office | 1,125 | 136 | $103.78 | $117K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 1,011 | 123 | $0.52 | $522 |
By year: 2022 $3.7M for 222,836 services; 2023 $3.8M for 224,681 services; 2024 $3.8M for 253,800 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,984 | 517 | $8.65 | $17K |
Medicare prescription drug claims, 2024
In 2024, the drug Leslie Tar prescribed most often to Medicare patients was Prednisone, with 483 prescriptions and refills. In total Leslie Tar wrote 4,544 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 483 | 1,174 | 178 | $4,589 |
| Leflunomide Generic | 367 | 934 | 134 | $20K |
| Methotrexate Methotrexate Sodium | 362 | 925 | 129 | $8,707 |
| Duloxetine Hcl Generic | 338 | 909 | 122 | $7,541 |
| Tramadol Hcl Generic | 302 | 306 | 78 | $2,973 |
| Montelukast Sodium Generic | 236 | 645 | 89 | $2,799 |
| Gabapentin Generic | 201 | 515 | 78 | $4,373 |
| Pregabalin Generic | 141 | 323 | 58 | $9,645 |
| Hydroxychloroquine Sulfate Generic | 91 | 215 | 38 | $1,528 |
| Levocetirizine Dihydrochloride Generic | 85 | 235 | 32 | $1,809 |
| Trazodone Hcl Generic | 84 | 224 | 30 | $1,243 |
| Alendronate Sodium Generic | 81 | 202 | 34 | $841 |
| Ropinirole Hcl Generic | 77 | 214 | 28 | $1,572 |
| Bupropion Hcl Sr Bupropion Hcl | 77 | 208 | 32 | $2,223 |
| Orencia Abatacept/Maltose | 69 | 69 | Under 11 | $294K |
Brand drugs: 556 claims; generic drugs: 3,988 claims; opioid claims: 306.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Leslie Tar were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.